30239384|t|Benzodiazepines for agitation in patients with delirium: selecting the right patient, right time, and right indication.
30239384|a|PURPOSE OF REVIEW: To provide an evidence-based synopsis on the role of benzodiazepines in patients with agitated delirium. RECENT FINDINGS: Existing evidence supports the use of benzodiazepines in two specific delirium settings: persistent agitation in patients with terminal delirium and delirium tremens. In the setting of terminal delirium, the goal of care is to maximize comfort, recognizing that patients are unlikely to recover from their delirium. A recent randomized trial suggests that lorazepam in combination with haloperidol as rescue medication was more effective than haloperidol alone for the management of persistent restlessness/agitation in patients with terminal delirium. In patients with refractory agitation, benzodiazepines may be administered as scheduled doses or continuous infusion for palliative sedation. Benzodiazepines also have an established role in management of delirium secondary to alcohol withdrawal. Outside of these two care settings, the role of benzodiazepine remains investigational and clinicians should exercise great caution because of the risks of precipitating or worsening delirium and over-sedation. SUMMARY: Benzodiazepines are powerful medications associated with considerable risks and benefits. Clinicians may prescribe benzodiazepines skillfully by selecting the right medication at the right dose for the right indication to the right patient at the right time.
30239384	0	15	Benzodiazepines	Chemical	MESH:D001569
30239384	20	29	agitation	Disease	MESH:D011595
30239384	33	41	patients	Species	9606
30239384	47	55	delirium	Disease	MESH:D003693
30239384	77	84	patient	Species	9606
30239384	192	207	benzodiazepines	Chemical	MESH:D001569
30239384	211	219	patients	Species	9606
30239384	234	242	delirium	Disease	MESH:D003693
30239384	299	314	benzodiazepines	Chemical	MESH:D001569
30239384	331	339	delirium	Disease	MESH:D003693
30239384	361	370	agitation	Disease	MESH:D011595
30239384	374	382	patients	Species	9606
30239384	397	405	delirium	Disease	MESH:D003693
30239384	410	426	delirium tremens	Disease	MESH:D000430
30239384	455	463	delirium	Disease	MESH:D003693
30239384	523	531	patients	Species	9606
30239384	567	575	delirium	Disease	MESH:D003693
30239384	617	626	lorazepam	Chemical	MESH:D008140
30239384	647	658	haloperidol	Chemical	MESH:D006220
30239384	704	715	haloperidol	Chemical	MESH:D006220
30239384	755	767	restlessness	Disease	MESH:D011595
30239384	768	777	agitation	Disease	MESH:D011595
30239384	781	789	patients	Species	9606
30239384	804	812	delirium	Disease	MESH:D003693
30239384	817	825	patients	Species	9606
30239384	842	851	agitation	Disease	MESH:D011595
30239384	853	868	benzodiazepines	Chemical	MESH:D001569
30239384	956	971	Benzodiazepines	Chemical	MESH:D001569
30239384	1019	1027	delirium	Disease	MESH:D003693
30239384	1041	1048	alcohol	Chemical	MESH:D000438
30239384	1109	1123	benzodiazepine	Chemical	MESH:D001569
30239384	1244	1252	delirium	Disease	MESH:D003693
30239384	1281	1296	Benzodiazepines	Chemical	MESH:D001569
30239384	1396	1411	benzodiazepines	Chemical	MESH:D001569
30239384	1513	1520	patient	Species	9606
30239384	Negative_Correlation	MESH:D006220	MESH:D003693
30239384	Cotreatment	MESH:D006220	MESH:D008140
30239384	Negative_Correlation	MESH:D008140	MESH:D003693
30239384	Negative_Correlation	MESH:D006220	MESH:D011595
30239384	Negative_Correlation	MESH:D008140	MESH:D011595
30239384	Negative_Correlation	MESH:D001569	MESH:D000430
30239384	Negative_Correlation	MESH:D001569	MESH:D011595
30239384	Negative_Correlation	MESH:D001569	MESH:D003693

